Contract facts
NONEFROZEN IV ANTIBIOTICS IDIQ W/ EO 14398 is a federal NONE award for 262-Network Contract Office 22 (36C262) held by Baxter Healthcare Corp. Estimated value —. Related solicitation 36C26226Q0904.
Incumbent footprint
Public recordBaxter Healthcare Corp — $25.7M obligated across 942 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26226D0102?
36C26226D0102 (FROZEN IV antibiotics IDIQ w EO 14398) is a 262-Network Contract Office 22 (36C262) award with an estimated value of —, currently held by Baxter Healthcare Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C262-26-D-0102?
36C262-26-D-0102 is the dashed form of PIID 36C26226D0102 (FROZEN IV antibiotics IDIQ w EO 14398), held by Baxter Healthcare Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26226D0102?
262-Network Contract Office 22 (36C262) awarded 36C26226D0102 to Baxter Healthcare Corp.
Who is the incumbent on 36C26226D0102?
Baxter Healthcare Corp is the incumbent with $25.7M across 942 related awards in SCOUT’s public footprint.
When does Baxter Healthcare Corp’s 36C26226D0102 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.